Alternative Approaches for Managing Blood Pressure in Children with Chronic Kidney Disease

Page last updated July 09, 2026

Study Design: Intervention Trial
PCORnet Infrastructure: Common Data Model (CDM), Single IRB, Patient partners or engagement, Clinical Research
Collaboration Agreement
Principal Investigator: Michelle Denburg
Institution: The Children’s Hospital of Philadelphia
PCORnet® Network Partner: PEDSnet
Funder: Patient-Centered Outcomes Research Institute (PCORI); (Project webpage)
Funding Date: 2026
Study Duration: 2026 – 2031
Participating PCORnet® Clinical Research Networks: GPC, INSIGHT, OneFlorida+, PEDSnet, PaTH, REACHnet, STAR
Therapeutic Area: Nephrology, Rare Diseases
Status: Not yet recruiting

Research Question(s):

1) What blood pressure threshold should be targeted for kidney and cardiovascular protection in children with CKD?

2) Should RAASi be first-line anti-hypertensive therapy for all children with CKD?

Implementation Program to Improve Screening and management for CKD in Diabetes (IRIS-CKD)

Page last updated May 11, 2026

ClinicalTrials.gov#: NCT06906627 - Program 1
ClinicalTrials.gov#:
 NCT06906640 - Program 2
Study Design:
Prospective Observational Study
PCORnet Infrastructure: Patient partners or engagement
Principal Investigator: Neha Pagidipati
Institution: Duke Clinical Research Institute
PCORnet® Network Partner: The Coordinating Center for PCORnet®
Funder: Industry (Bayer, Boehringer Ingelheim, Lilly)
Funding Date: 2024
Study Duration: 2024 – 2026
Participating PCORnet® Clinical Research Networks: INSIGHT, OneFlorida+, PaTH, REACHnet, STAR 
Therapeutic Area: Nephrology
Condition: CKD in Diabetes
Status: Recruiting

Research Question(s):
IRIS-CKD is a project focused on improving how doctors check for and treat chronic kidney disease (CKD) in people with type 2 diabetes (T2D). The main goals of the project are to:

  • Increase the number of people with type 2 diabetes who get screened for chronic kidney disease.
  • Ensure that more patients with both chronic kidney disease and type 2 diabetes receive the treatments recommended by medical guidelines.